James Y. Suen, M.D. is Director of the Arkansas Cancer Research Center, and Chairman/Professor of Otolargynology at UAMS. His clinical interersts include head and neck oncology, thyroid tumors, vascular lesions, laser therapy, voice disorders, reconstructive surgery of the head and neck. Dr. Suen’s research interests include gene therapy of head and neck cancer, laser therapy, immunology and cancer.

Selected Publications:

North PE, Waner M, Mizeracki A, Suen JY, Mihm MC: A Unique Microvascular Phenotype Shared by Juvenile Hemangiomas and Human Placentas. Arch Dermatol. Vol 137, May 2001.

Li S, Xia X, Zhang X, Suen JY: Regression of tumors by IFN-a Electroporation Gene Therapy and Analysis of the Responsible Genes by cDNA Array. Gene Therapy. 2002; 9:390-397.

Fife RS, Chase WF, Dore RK, Wiesenhutter CW, Lockhart PB, Tindall E, Suen JY: Cevimeline for the Treatment of Xerostomia in Patients with Sjögren Syndrome. Archives of Internal Medicine. 2002;162:1293-1300

Mukunyadzi P, Liu KL, Hanna E, Suen JY, Fan CY: Induced expression of Syndecan-1 in the Stroma of Head and Neck Squamous Cell Carcinoma (HNSCC). Modern Pathology. 2003: 16:796-801.

Myers EN. Suen JY. (eds) Cancer of the Head and Neck, Fourth Edition. W. B. Saunders, New York, NY, 2003.